It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Follicular helper T (Tfh) cells are essential for germinal center (GC) B cell responses. However, it is not clear which PD-1+CXCR5+Bcl6+CD4+ T cells will differentiate into PD-1hiCXCR5hiBcl6hi GC-Tfh cells and how GC-Tfh cell differentiation is regulated. Here, we report that the sustained Tigit expression in PD-1+CXCR5+CD4+ T cells marks the precursor Tfh (pre-Tfh) to GC-Tfh transition, whereas Tigit–PD-1+CXCR5+CD4+ T cells upregulate IL-7Rα to become CXCR5+CD4+ T memory cells with or without CCR7. We demonstrate that pre-Tfh cells undergo substantial further differentiation at the transcriptome and chromatin accessibility levels to become GC-Tfh cells. The transcription factor c-Maf appears critical in governing the pre-Tfh to GC-Tfh transition, and we identify Plekho1 as a stage-specific downstream factor regulating the GC-Tfh competitive fitness. In summary, our work identifies an important marker and regulatory mechanism of PD-1+CXCR5+CD4+ T cells during their developmental choice between memory T cell fate and GC-Tfh cell differentiation.
It is debated how follicular helper T (Tfh) cells versus central memory CD4+ T cells arise from similar precursors, and little is known about the regulation of germinal-centre (GC)-Tfh cell differentiation. Here, authors establish markers in the early precursor stage that distinguish between the GC-Tfh and memory T cell fates and identify an important mechanism that regulates the competitive fitness of the GC-Tfh cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Alabama at Birmingham, Department of Microbiology, School of Medicine, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187)
2 University of Alabama at Birmingham, Department of Pathology, School of Medicine, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187)
3 University of Alabama at Birmingham, Department of Medicine, School of Medicine, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187)
4 La Jolla Institute for Immunology, Division of Signaling and Gene Expression, La Jolla, USA (GRID:grid.185006.a) (ISNI:0000 0004 0461 3162)
5 The Scripps Research Institute, Department of Immunology and Microbiology, Jupiter, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
6 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
7 University of Science, Faculty of Pharmaceutical Sciences, Tokyo, Chiba, Japan (GRID:grid.143643.7) (ISNI:0000 0001 0660 6861)